IP Library › Granted Patent US 10,390,946
Granted Patent B2
US 10,390,946 · App. 14/671,112 · Granted Aug 27, 2019

Method for the preparation of biological tissue for dry use in an implant

Inventors: Nina Lehenberger (Fuerth, DE); Alexander Rzany (Nuremberg, DE); Wilhelm Erdbruegger (Constance, DE)
Assignee: Biotronik AG
A61F2/2418A61F2/2427A61L27/367A61L27/3625A61L27/3687A61F2240/001A61L2400/02A61L2400/18A61L2430/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,390,946
App. No.
14/671,112
Granted
Aug 27, 2019
Kind
B2
Abstract

A method of preparing biological tissue for use as a component of an implant, in particular as part of a heart valve prosthesis, which can be implanted by catheter. The biological tissue is subjected to a dimensional and structural stabilization step and is dried. For the dimensional and structural stabilization, a combination of a first, polyethylene glycol-containing solution and at least one second, glycerol-containing solution is used.

Claims (16)

1. A method of preparing biological tissue for use as a component of a heart valve prosthesis comprising pretreating the tissue, and stabilizing the pretreated tissue, characterized in that, the step of pretreating the tissue comprises crosslinking the tissue with an aldehyde-containing solvent, wherein the aldehyde is glutaraldehyde or formaldehyde; and the step of stabilizing the pretreated tissue comprises exposing the tissue to three solutions for dimensional and structural stabilization, wherein a first solution contains polyethylene glycol having a mean molecular weight between 200 g/mol and 400 g/mol, a second solution contains glycerol, and a third solution contains polyethylene glycol having a mean molecular weight between 1,000 g/mol and 6,000 g/mol, wherein the tissue is exposed to the first and second solutions before the third solution.

2. The method according to claim 1 , characterized in that the tissue is exposed to the first or the third solution for 1 to 12 hours.

3. The method according to claim 1 , characterized in that the polyethylene glycol is present in the first or the third solution in a concentration of 5 vol % to 60 vol %.

4. The method according to claim 1 , characterized in that glycerol is contained in the second solution in a concentration of 5 vol % to 50 vol %.

5. The method according to claim 1 , further comprising decellularizing the tissue with a suitable detergent prior to the cross-linking.

6. The method according to claim 1 , further comprising drying the stabilized tissue.

7. The method according to claim 1 , characterized in that the polyethylene glycol in the third solution has a mean molecular weight of 4,000-6,000 g/mol.

8. The method according to claim 2 , characterized in that the tissue is exposed to the first or the third solution for 2 to 6 hours.

9. The method according to claim 3 , characterized in that the polyethylene glycol is present in the first or the third solution in a concentration of 10 vol % to 40 vol %.

10. The method according to claim 4 , characterized in that glycerol is contained in the second solution in a concentration of 5 vol % to 30 vol %.

11. The method according to claim 5 , characterized in that the detergent is a solution containing surfactin and deoxycholic acid.

12. The method according to claim 1 , wherein the third solution contains 30 vol % polyethylene glycol.

13. A method of preparing biological tissue for use as a component of a heart valve prosthesis, the method comprising: crosslinking the tissue with glutaraldehyde or formaldehyde; treating the crosslinked tissue in an aqueous solution of polyethylene glycol and glycerol, the polyethylene glycol having a mean molecular weight between 200 g/mol and 1,000 g/mol; and placing the treated tissue in an aqueous solution of 30 vol % polyethylene glycol having a mean molecular weight between 1,000 g/mol and 6,000 g/mol and 10% glycerol.

14. The method according to claim 13 , wherein the polyethylene glycol between 200 g/mol and 1,000 g/mol is between 400 g/mol and 600 g/mol.

15. The method according to claim 13 , wherein the polyethylene glycol between 200 g/mol and 1,000 g/mol is between 200 g/mol and 400 g/mol.

16. The method according to claim 15 , wherein the polyethylene glycol between 200 g/mol and 400 g/mol is at 30 vol %.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2015
From: LEHENBERGER, NINA; RZANY, ALEXANDER, DR.; ERDBRUEGGER, WILHELM, DR.
To: BIOTRONIK AG
Reel/Frame 035275/0213 →
Priority Claims (1)
EP 14163120 · Apr 2, 2014 · regional
Continuity (1)
Related Publication 20150282930A1 · Oct 8, 2015